[Some considerations on the Consensus of the Spanish Diabetes Society and the Spanish Society of Family and Community Medicine on the criteria and guidelines for combined therapy for type 2 diabetes].
González-Clemente
J M
JM
Giménez-Pérez
G
G
Caixàs
A
A
Mauricio
D
D
D020909:Acarbose / Q000008:administration & dosage / Q000627:therapeutic use; D001786:Blood Glucose / Q000032:analysis; D003154:Community Medicine; D003245:Consensus Statements as Topic; D018849:Controlled Clinical Trials as Topic; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D005194:Family Practice; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D008687:Metformin / Q000008:administration & dosage / Q000627:therapeutic use; D009765:Obesity / Q000150:complications; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors; D012955:Societies, Medical; D013030:Spain; D013997:Time Factors
D001786:Blood Glucose; D007004:Hypoglycemic Agents; D008687:Metformin; D020909:Acarbose